Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humatrope Extension in Non-GHD Short Stature
NCT00191074Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2001
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of somatropin in Idiopathic Short Stature (ISS), sponsored by Eli Lilly and Company. Primary endpoints: Height, Weight and 7 more. Started Feb 2001; status: completed.
02
Drugs
somatropin
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on NCT00191074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00191074.